Near-Infrared Spectroscopy (NIRS) enables straightforward multiparameter analysis of critical parameters for monitoring the refining of hydrocarbons. NIRS is a nondestructive secondary analysis method, NIRS does not require any handling of chemicals whatsoever, and real-time measurements are performed at the push of a button. NIRS is the ideal method for a wide range of applications: Distillation... Read more
Kremsmünster/Rainbach/Frickenhausen, April 4, 2016 – Greiner Bio-One, a leading international medical technology company and part of Greiner Holding AG, will in future limit its activities in the diagnostics field to the production and distribution of existing products. Greiner Bio-One Diagnostics GmbH, which is based in Rainbach im Mühlkreis, develops molecular analysis methods that enable bacteria... Read more
FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com March 24, 2016 Peabody, MA — JEOL is honored to announce that the company founders were recognized for their scientific vision and pioneering leadership at Pittcon 2016 in Atlanta, Georgia. President and CEO of the Chemical Heritage Foundation, Carsten Reinhardt, presented the Pittcon Heritage Award... Read more
2016 2016/03/22 Takara Bio grants Cellectis SA a commercial license to use RetroNectin® Kusatsu/Shiga, Japan – March 22, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Cellectis SA. Under the agreement, Takara Bio grants Cellectis a commercial license to use RetroNectin® and Takara Bio also supplies RetroNectin® to Cellectis . ... Read more
BARRINGTON, IL., March 9, 2016 — GE Healthcare (NYSE: GE) today announced the appointment of Charles Koontz as president and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer, effective March 14. Koontz succeeds Jan De Witte, who is leaving GE. Koontz joins GE from Computer Sciences Corp (CSC) and CSRA, where he was... Read more